Breaking News Instant updates and real-time market news.

GS

Goldman Sachs

$218.06

3.97 (1.85%)

, BAC

Bank of America

$23.07

0.33 (1.45%)

18:57
04/20/17
04/20
18:57
04/20/17
18:57

Trump expected to sign 2 finance-related executive orders, CNBC says

U.S. president Donald Trump is anticipated to sign two "financial related" executive orders at the Treasury tomorrow, CNBC reports, citing a White House official and another person familiar with the matter. The White House said that one of the orders will be a presidential memorandum on orderly liquidation authority, the report says. Publicly traded companies in the space include Bank of America (BAC), Citi (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC). Reference Link

GS

Goldman Sachs

$218.06

3.97 (1.85%)

BAC

Bank of America

$23.07

0.33 (1.45%)

C

Citi

$58.41

0.68 (1.18%)

WFC

Wells Fargo

$53.50

1.35 (2.59%)

JPM

JPMorgan

$85.55

1.09 (1.29%)

MS

Morgan Stanley

$42.50

0.46 (1.09%)

USB

U.S. Bancorp

$50.68

0.99 (1.99%)

  • 20

    Apr

  • 20

    Apr

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 09

    May

  • 11

    May

  • 19

    May

  • 22

    May

  • 06

    Jun

  • 14

    Jul

  • 14

    Jul

  • 18

    Jul

  • 19

    Jul

  • 25

    Jul

  • 12

    Oct

  • 13

    Oct

  • 17

    Oct

  • 18

    Oct

  • 15

    Jan

  • 17

    Jan

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

GS Goldman Sachs
$218.06

3.97 (1.85%)

04/20/17
04/20/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Starbucks (SBUX) upgraded to Buy from Hold at Stifel with analyst Mark Astrachan saying he views valuation as attractive and expects multiple expansion from accelerating U.S. comparable store sales growth to at least 5%-6% for the next four quarters starting in the June quarter. The analyst said shares have underperformed consumer and restaurant peers over the past 12 months and expects outperformance to be driven by meeting comp expectations. 2. Goldman Sachs (GS) upgraded to Overweight from Neutral at Atlantic Equities with analyst Christopher Wheeler telling investors investors shares are "oversold." The analyst expects the FICC business to bounce back and made just a small reduction in estimates to account for further cost measures. 3. Lear (LEA) upgraded to Outperform from Neutral at Baird with analyst David Leiker citing its recent underperformance despite improving fundamentals and a strong global auto backdrop. Leiker raised his price target to $161 from $160 on Lear shares. 4. Discovery (DISCA) upgraded to Neutral from Sell at Citi with analyst Jason Bazinet saying he sees little chance of material downward revisions to consensus earnings estimates. The analyst views the risk/reward as more balanced at current levels and upped his price target for the shares to $30 from $27. 5. Gap (GPS) upgraded to Neutral from Underweight at JPMorgan with analyst Matthew Boss citing the underperformance of the shares over the past 18 months and his fieldwork which suggests stability at Old Navy. The analyst raised his price target for the shares to $24 from $21. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/20/17
ATLE
04/20/17
UPGRADE
Target $252
ATLE
Overweight
Goldman Sachs upgraded to Overweight, shares 'oversold,' says Atlantic Equities
Atlantic Equities analyst Christopher Wheeler upgraded Goldman Sachs to Overweight from Neutral and lowered his price target to $252 from $254 telling investors investors shares are "oversold." The analyst expects the FICC business to bounce back and made just a small reduction in estimates to account for further cost measures.
04/19/17
04/19/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Goldman Sachs (GS) upgraded to Neutral from Sell at Citi with analyst Keith Horowitz saying yesterday's post-earnings selloff took out the excess valuation premium. The analyst believes the risk/reward is now more balanced. He keeps a $225 price target for Goldman shares. 2. HP Inc. (HPQ) upgraded to Overweight from Equal Weight at Barclays with analyst Mark Moskowitz saying he expects earnings to return later this year amid improving PC trends and the end of the printing supplies glut. 3. WestRock (WRK) upgraded to Outperform from Sector Perform at RBC Capital and to Buy from Neutral at Goldman Sachs. 4. Coca-Cola (KO) upgraded to Outperform from Neutral at Credit Suisse with analyst Laurent Grandet saying with incoming CEO James Quincey taking over on May 1, and the refranchising nearly complete, Coca-Cola "has all the pieces in place to be successful again." The company has "significant balance sheet flexibility" to invest in the business and fill the gaps in the current portfolio, the analyst adds. 5. Fastenal (FAST) upgraded to Outperform from Neutral at Credit Suisse with analyst Andrew Buscaglia saying the selloff since the first quarter report has created a buying opportunity. The analyst views Fastenal as a best-in-class distributor with significant manufacturing exposure with very high operating leverage in an upcycle. Buscaglia said a recent private distributor survey indicates a majority of respondents expect price increases over the next three months and believe the company may be able to increase prices, which would surprise the Street. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/19/17
ARGS
04/19/17
NO CHANGE
ARGS
Goldman Sachs reported 'solid' Q1 results, says Argus
Argus analyst Stephen Biggar says that Goldman reported "solid" Q1 results, but he says that earnings expectations for the company were "inflated,." Biggar thinks that the company faces difficult comparisons in some of its business lines after reporting strong 2016 results. He keeps a Hold rating on the shares.
BAC Bank of America
$23.07

0.33 (1.45%)

04/19/17
RBCM
04/19/17
NO CHANGE
RBCM
Bank of America reported 'knockout' results, says RBC Capital
RBC Capital analyst Gerard Cassidy says that Bank of America reported "knockout" Q1 results that were better than the other three "Big Four" banks. The analyst says that the company has momentum heading into the rest of the year. He keeps a $26 price target and an Outperform rating on the shares.
04/04/17
04/04/17
NO CHANGE

Mrogan Stanley recommends buying large banks on weakness after Q1 results
Morgan Stanley analyst Betsy Graseck expects most large banks she covers to report weaker than expected Q1 results. However, the analyst recommends that investors buy the large-cap bank stocks on weakness, as she expects them to benefit from "stronger capital return, easing regulation, lower taxes and higher rates in 2H17," along with an improved GDP outlook and strong expense management. Graseck identifies Citi (C) as her top pick heading into the quarter, as she expects its Q1 results to beat expectations, driven by strength in emerging markets and "repositioning investments" that have started to beat fruit. She expects the bank to get a boost from CCAR in June and says that it is "the biggest beneficiary of easing regulation." Other publicly traded companies in the space include Bank of America (BAC), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC).
04/06/17
EVER
04/06/17
NO CHANGE
EVER
Glass-Steagall return wouldn't find support in Congress, says Evercore ISI
After media reports claimed White House economic adviser Gary Cohn supports rules to make banks split their consumer lending units from their investment divisions, which hints at a return of the "Glass-Steagall" law that was ended by President Clinton and a Republican Congress in 1999, Evercore ISI analyst Terry Haines said there is little support in Congress for a return of the law. Any new bank regulations can't "be done with the stroke of a pen" and will have to go through the usual regulatory process, added Haines. Publicly traded large banks include Bank of America (BAC), Citi (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC).
04/04/17
04/04/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) downgraded to Market Perform from Outperform at BMO Capital with analyst Daniel Salmon saying Amazon's (AMZN) ad business represents Google's biggest competitive headwind since Facebook (FB). The analyst believes Google can still grow revenue at 15%-20% over the mid-and long term, but he sees a lower likelihood of topping expectations as Amazon's ad business rises. Salmon continues to prefer Alphabet shares to Facebook, however. He moved Amazon to his top pick this morning and upped his price target for the shares to $1,200. 2. NVIDIA (NVDA) downgraded to Underweight from Sector Weight at Pacific Crest. 3. Nike (NKE) downgraded to Hold from Buy at Argus with analyst John Staszak saying he expects the company's growth to slow over the next 12 months due to competition from Adidas (ADDYY) and Under Armour (UAA). 4. Urban Outfitters (URBN) and L Brands (LB) were downgraded to Neutral from Buy at Citi. 5. Bank of America (BAC) downgraded to Neutral from Buy at Citi with analyst Keith Horowitz saying the stock's outperformance since the U.S. election has substantially closed the valuation gap with JPMorgan (JPM). "We do not see a lot left to play for," Horowitz tells investors in a research note. He lowered his price target for Bank of America shares to $25 from $26. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
C Citi
$58.41

0.68 (1.18%)

04/13/17
PIPR
04/13/17
NO CHANGE
PIPR
Neutral
Piper sees Wells Fargo underperforming peers today on 'lower quality' earnings
Piper Jaffray analyst Kevin Barker estimates operating earnings of 98c per share at Wells Fargo (WFC) in Q1 after adjusting for tax and hedging, also noting that its net interest margin was flat despite the increase in rates and that its efficiency ratio jumped "well above" the bank's long-term target. Citing what he views as "lower quality" earnings, Barker expects Wells Fargo shares to underperform peers today. JPMorgan (JPM), Citi (C) and PNC Financial (PNC) all also reported results this morning. Barker keeps a Neutral rating on Wells Fargo shares.
04/13/17
NOMU
04/13/17
NO CHANGE
NOMU
'Many think Wells Fargo EPS came in below expectations, says Nomura Instinet
Nomura Instinet analyst Bill Carcache says that "many investors" believe that Wells Fargo's Q1 EPS came in below expectations, given the 3c per share in reserve releases and the 7c per share profit it realized on "market-sensitive revenues" it reported. The analyst says that the "Results were characterized by softer- than-expected top-line growth, higher expenses, and lower provision." He notes that Wells Fargo, like JPMorgan (JPM) and Citi (C), reported slower loan growth. However, he keeps a Buy rating on Wells Fargo.
04/05/17
04/05/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Staples (SPLS) upgraded to Buy from Neutral at Citi with analyst Kate McShane saying her sum-of-the-parts analysis indicates the company should be worth closer to $7.9B versus the current market capitalization of $5.6B. This implies 30% upside for the shares, McShane tells investors in a research note after the Wall Street Journal reported Staples is exploring a possible sale. The analyst believes the exploration makes sense. She upped her price target for Staples to $12 from $9.50. 2. Wells Fargo (WFC) and Citi (C) upgraded to Outperform from Market Perform at Keefe Bruyette. 3. McCormick (MKC) upgraded to Neutral from Underweight at JPMorgan with analyst Ken Goldman saying he continues to view the stock as overvalued but notes management "sounded highly confident about current fundamentals." 4. Wynn Resorts (WYNN) upgraded to Buy from Hold at Argus with analyst John Staszak saying the company is benefiting from the "consistent improvement" of its Wynn Palace casino in Macau, along with the overall improvement of the Macau gambling market in general and the faster than expected rebound of the Macau VIP market in particular. 5. GlaxoSmithKline (GSK) upgraded to Neutral from Underperform at Exane BNP Paribas. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
WFC Wells Fargo
$53.50

1.35 (2.59%)

04/12/17
04/12/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Sell from Hold at Rafferty Capital with analyst Richard Bove saying he does not expect bank stocks in general to do well for months and he thinks on Wells specifically that its Directors report indicates that the company is in the midst of a multi-year re-structuring process. Bove lowered his 12-month price target range for Wells Fargo shares to $46-$60 from $52-$68. 2. Tractor Supply (TSCO) was downgraded to Equal Weight from Overweight at Stephens and to Neutral from Overweight at JPMorgan. 3. Avinger (AVGR) downgraded to Perform from Outperform at Oppenheimer with analyst Steven Lichtman downgraded Avinger (AVGR) to Perform from Outperform after its Q1 sales came in below estimates on lower than expected Pantheris utilization and following the company's announcement that it plans to reduce its workforce by 33%, while pursuing strategic alternatives, including a capital raise from strategic investors, OUS partnerships, or a merger/sale. 4. Louisiana-Pacific (LPX) downgraded to Neutral from Buy at Buckingham with the firm citing recent share strength that has made risk/reward more balanced. 5. LVMH (LVMUY) downgraded to Hold from Buy at Societe Generale with analyst Thierry Cota citing a lack of upside following the stock's recent rally. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/12/17
04/12/17
DOWNGRADE

Sell
Wells Fargo downgraded to Sell at Rafferty Capital
As previously reported, Rafferty Capital analyst Richard Bove downgraded Wells Fargo to Sell from Hold. Bove does not expect bank stocks in general to do well for months and he thinks on Wells specifically that its Directors report indicates that the company is in the midst of a multi-year re-structuring process. Bove lowered his 12-month price target range for Wells Fargo shares to $46-$60 from $52-$68.
JPM JPMorgan
$85.55

1.09 (1.29%)

04/19/17
OPCO
04/19/17
NO CHANGE
OPCO
Oppenheimer bullish on Visa, MasterCard ahead of results
Oppenheimer analyst Glenn Greene reiterates Outperform ratings for MasterCard (MA) and Visa (V) and $120 and $95 price targets, respectively, heading into results. The analyst is encouraged by "solid" January intra-quarter volume growth, improving gas price trends, strong retail sales growth, and broadly positive card issuer trends. Further, Greene continues to believe that MasterCard and Visa are attractive at current levels, given their defensible market positions and strong long-term prospects. Nonetheless, he prefers Visa relative to MasterCard at present given the continuing U.S. volume boost from the Costco (COST)/USAA wins and JPMorgan Chase (JPM) Sapphire Reserve momentum, apparent conservative guidance, and Visa Europe accretion benefits.
MS Morgan Stanley
$42.50

0.46 (1.09%)

03/29/17
03/29/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Morgan Stanley (MS) upgraded to Buy from Hold at Deutsche Bank with analyst Matt O'Connor citing the recent 10% pullback in the shares and his optimism for capital markets beyond the first quarter. 2. Capital One (COF) upgraded to Buy from Neutral at Nomura with analyst Bill Carcache saying most card issuers have reduced their sub-prime exposure since 2011, but Capital One has increased its subprime mix by 500 bps and is positioned to reap the rewards. Carcache expects Capital One's net income and earning to inflect in 2017 and 2018 with healthy high-single-digit card loan growth continuing, while the need to build reserves abates. The analyst adds, even with no Trump tax or regulatory policy tailwinds, Capital One should put up double-digit earnings growth in 2017 and 2018. 3. Ericsson (ERIC) upgraded to Outperform from Market Perform at Bernstein with analyst Pierre Ferragu saying the company's restructuring plan skews the risk/reward to the upside. 4. Chemours (CC) upgraded to Buy from Hold at Jefferies with analyst Laurence Alexander saying while the stock has rallied as a trade on cyclical leverage and litigation relief, structural improvements in TiO2 and fluoropolymers could bring further upside. 5. Vertex (VRTX) upgraded to Outperform from Market Perform at BMO Capital. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/29/17
DBAB
03/29/17
UPGRADE
Target $47
DBAB
Buy
Morgan Stanley upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Matt O'Connor upgraded Morgan Stanley (MS) to Buy citing the recent 10% pullback in the shares and his optimism for capital markets beyond Q1. Continued successful execution within FICC will support a higher multiple, O'Connor tells investors in a research note. He raised his price target for Morgan Stanley shares to $47 from $43. Goldman Sachs (GS) and Wells Fargo (WFC) are the analyst's other top picks among the U.S. Banks.
USB U.S. Bancorp
$50.68

0.99 (1.99%)

01/11/17
UBSW
01/11/17
INITIATION
Target $60
UBSW
Buy
U.S. Bancorp initiated with a Buy at UBS
UBS analyst Saul Martinez started U.S. Bancorp with a Buy rating and $60 price target. The analyst calls the company his top pick in the Americas Banks sector.
04/20/17
RAFF
04/20/17
DOWNGRADE
RAFF
Hold
U.S. Bancorp downgraded to Hold from Buy at Rafferty Capital

TODAY'S FREE FLY STORIES

GM

General Motors

$39.42

0.32 (0.82%)

11:43
09/23/17
09/23
11:43
09/23/17
11:43
Periodicals
GM to eliminate shift at Tennessee SUV plant on 'moderating' sales, WSJ says »

General Motors has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.25

0.19 (0.35%)

11:34
09/23/17
09/23
11:34
09/23/17
11:34
Periodicals
Wells Fargo hires law firm to prepare CEO for Senate appearance, Reuters says »

Wells Fargo has hired law…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

  • 13

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

EADSY

Airbus

$23.06

-0.01 (-0.04%)

11:27
09/23/17
09/23
11:27
09/23/17
11:27
Periodicals
Airbus in talks to sell all or part of Premium Aerotec, Reuters says »

Airbus is said to be in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

$102.11

0.56 (0.55%)

11:06
09/23/17
09/23
11:06
09/23/17
11:06
Hot Stocks
Quest Diagnostics 'disappointed' with proposed PAMA 2018 Medicare payment rates »

Quest Diagnostics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

IRBT

iRobot

$76.14

-3.8 (-4.75%)

10:58
09/23/17
09/23
10:58
09/23/17
10:58
Periodicals
iRobot suffering after onslaught of SharkNinja cheaper models, Barron's says »

In a follow up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$69.33

0.42 (0.61%)

, SNPS

Synopsys

$80.36

0.3 (0.37%)

10:47
09/23/17
09/23
10:47
09/23/17
10:47
Periodicals
Xilinx, Synopsys are 'rising stars' amid natural evolution of AI, Barron's says »

As everyday items get…

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

UTX

United Technologies

$115.01

0.51 (0.45%)

, COL

Rockwell Collins

$130.48

0.09 (0.07%)

10:42
09/23/17
09/23
10:42
09/23/17
10:42
Periodicals
Major aircraft makers, suppliers face off, Barron's says »

While United Technologies…

UTX

United Technologies

$115.01

0.51 (0.45%)

COL

Rockwell Collins

$130.48

0.09 (0.07%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

GPRO

GoPro

$10.75

-0.19 (-1.74%)

10:33
09/23/17
09/23
10:33
09/23/17
10:33
Periodicals
Key events may create 'short squeeze' in GoPro stock, Barron's says »

GoPro, a heavily shorted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMC

Honda

$29.91

0.18 (0.61%)

, RACE

Ferrari

$113.47

-0.1 (-0.09%)

10:17
09/23/17
09/23
10:17
09/23/17
10:17
Periodicals
Honda $200,000 Acura NSX lacks Ferrari 'raw appeal,' Barron's says »

Acura, Honda's (HMC)…

HMC

Honda

$29.91

0.18 (0.61%)

RACE

Ferrari

$113.47

-0.1 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$48.16

0.19 (0.40%)

10:07
09/23/17
09/23
10:07
09/23/17
10:07
Periodicals
Oracle shares could return 20% in a year, Barron's says »

Oracle is a latecomer to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.96

1.14 (1.97%)

09:59
09/23/17
09/23
09:59
09/23/17
09:59
Periodicals
Six Flags may have peaked, Barron's says »

Investors have had an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

, AVXS

AveXis

$92.11

-4.03 (-4.19%)

09:51
09/23/17
09/23
09:51
09/23/17
09:51
Periodicals
Gene therapy may be nearing 'major breakthrough,' Baron's says »

Gene therapy is rapidly…

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

AVXS

AveXis

$92.11

-4.03 (-4.19%)

RGNX

Regenxbio

$28.25

-1.15 (-3.91%)

BOLD

Audentes Therapeutics

$27.31

-0.1 (-0.36%)

VYGR

Voyager Therapeutics

$17.50

-0.22 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 12

    Oct

  • 12

    Jan

  • 22

    Sep

AET

Aetna

$153.57

0.18 (0.12%)

, ANTM

Anthem

$182.86

-0.64 (-0.35%)

09:25
09/23/17
09/23
09:25
09/23/17
09:25
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CNC

Centene

$92.22

1.48 (1.63%)

CI

Cigna

$182.74

0.61 (0.33%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

WCG

WellCare

$167.16

1.1 (0.66%)

AOBC

American Outdoor Brands

$15.01

-0.15 (-0.99%)

RGR

Sturm, Ruger

$51.00

-1.85 (-3.50%)

WMT

Wal-Mart

$79.53

-0.48 (-0.60%)

PEP

PepsiCo

$111.85

-0.95 (-0.84%)

TGT

Target

$58.99

0.66 (1.13%)

AAPL

Apple

$151.89

-1.5 (-0.98%)

MSFT

Microsoft

$74.41

0.2 (0.27%)

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

TWTR

Twitter

$17.61

0.03 (0.17%)

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

  • 22

    Oct

  • 24

    Oct

  • 08

    Nov

  • 16

    Nov

  • 21

    Nov

  • 29

    Nov

  • 20

    Feb

AVA

Avista

$51.40

0.1 (0.19%)

18:47
09/22/17
09/22
18:47
09/22/17
18:47
Hot Stocks
Avista receives commission decision in Oregon natural gas rate case »

Avista's natural gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

BMWYY

BMW

$34.00

0.083 (0.24%)

18:40
09/22/17
09/22
18:40
09/22/17
18:40
Periodicals
BMW to build new 8 series in Dingolfing from 2018, Reuters reports »

BMW intends to build its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$33.37

0.67 (2.05%)

18:20
09/22/17
09/22
18:20
09/22/17
18:20
Hot Stocks
Cisco completes acquisition of Springpath »

Cisco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 15

    Nov

  • 07

    Dec

  • 11

    Dec

BMY

Bristol-Myers

$63.36

0.03 (0.05%)

18:12
09/22/17
09/22
18:12
09/22/17
18:12
Hot Stocks
Bristol-Myers announces FDA approval of Opdivo »

Bristol-Myers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 26

    Oct

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

INSE

Inspired Entertainment

$13.60

0.3 (2.26%)

17:38
09/22/17
09/22
17:38
09/22/17
17:38
Hot Stocks
Inspired Entertainment COO Wilson leaving by reason of redundancy »

On September 21, Inspired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

MNOV

MediciNova

$6.18

0.3 (5.10%)

17:30
09/22/17
09/22
17:30
09/22/17
17:30
Syndicate
Breaking Syndicate news story on MediciNova »

MediciNova files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ISRG

Intuitive Surgical

$1,031.52

1.31 (0.13%)

17:25
09/22/17
09/22
17:25
09/22/17
17:25
Conference/Events
Intuitive Surgical to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

GD

General Dynamics

$205.41

-0.31 (-0.15%)

17:21
09/22/17
09/22
17:21
09/22/17
17:21
Hot Stocks
General Dynamics Electric Boat awarded $341.2M government contract modification »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHRS

Coherus Biosciences

$12.85

0.3 (2.39%)

17:19
09/22/17
09/22
17:19
09/22/17
17:19
Syndicate
Breaking Syndicate news story on Coherus Biosciences »

Coherus Biosciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FIBK

First Interstate

$36.90

0.3 (0.82%)

17:18
09/22/17
09/22
17:18
09/22/17
17:18
Syndicate
First Interstate files to sell $250M of Class A common stock »

The shelf registration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

, NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

17:08
09/22/17
09/22
17:08
09/22/17
17:08
Hot Stocks
National Research launches metric to measure healthcare consumer loyalty »

NRC Health launched the…

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$51.79

-0.16 (-0.31%)

, HON

Honeywell

$141.75

0.89 (0.63%)

16:58
09/22/17
09/22
16:58
09/22/17
16:58
Hot Stocks
Chemours files appeal concerning SNAP 20 rule to regulate HFCs »

The Chemours Company (CC)…

CC

Chemours

$51.79

-0.16 (-0.31%)

HON

Honeywell

$141.75

0.89 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.